MarketCap
Facebook
X
TelegramQuartalsbericht 2026-Q1
hinzugefügt 23.05.2026
Emergent BioSolutions EV/EBITDA 2011-2026 | EBS
EV/EBITDA Jährlich Emergent BioSolutions
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5.32 | 12.6 K | -2 | -64.7 | 7.77 | 12 | 20.2 | 32.4 | 11.5 | 8.28 | 10.3 | 11.2 | 12 | 9.85 | 12.7 | 5.52 | 5.5 | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 12.6 K | -64.7 | 744 |
EV/EBITDA anderer Aktien in der Arzneimittelhersteller
| Name | EV/EBITDA | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Endo International plc
ENDP
|
-2.32 | - | - | $ 28.9 M |  Irlanda |
 |
Evoke Pharma
EVOK
|
0.599 | - | - | $ 36.6 M |  USA |
 |
Cumberland Pharmaceuticals
CPIX
|
45.3 | $ 5.72 | -2.39 % | $ 85 M | USA |
 |
HEXO Corp.
HEXO
|
-0.524 | - | 2.45 % | $ 38.1 M |  Canada |
 |
Calliditas Therapeutics AB (publ)
CALT
|
2.61 | - | -0.1 % | $ 2.03 B |  Schweden |
 |
AcelRx Pharmaceuticals
ACRX
|
-0.504 | - | 7.5 % | $ 6.35 M | USA |
 |
DURECT Corporation
DRRX
|
0.585 | - | - | $ 50.1 M | USA |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
-1.21 | - | 0.86 % | $ 117 M | USA |
 |
Aerie Pharmaceuticals
AERI
|
-18.4 | - | - | $ 754 M | USA |
 |
Agile Therapeutics
AGRX
|
-1.28 | - | 10.11 % | $ 58.2 M | USA |
 |
Alimera Sciences
ALIM
|
28.9 | - | - | $ 142 M | USA |
 |
Cronos Group
CRON
|
0.428 | $ 2.79 | 0.72 % | $ 1.07 B | Canada |
 |
Athenex
ATNX
|
-3.19 | - | -23.39 % | $ 1.76 M | USA |
 |
Harrow Health
HROW
|
69.4 | $ 33.46 | 1.09 % | $ 1.23 B | USA |
 |
Avadel Pharmaceuticals plc
AVDL
|
-19 | - | - | $ 2.06 B |  France |
 |
Catalent
CTLT
|
-64.3 | - | - | $ 11.5 B | USA |
 |
Organogenesis Holdings
ORGO
|
6.81 | $ 2.48 | 4.2 % | $ 314 M | USA |
 |
Eagle Pharmaceuticals
EGRX
|
160 | - | -39.89 % | $ 27.7 M | USA |
 |
Canopy Growth Corporation
CGC
|
-4.28 | $ 1.02 | - | $ 110 M | Canada |
 |
Pacira BioSciences
PCRX
|
29.6 | $ 23.21 | 1.53 % | $ 1.07 B | USA |
 |
Sonoma Pharmaceuticals
SNOA
|
-4.16 | $ 1.11 | 1.83 % | $ 1.38 M | USA |
 |
Solid Biosciences
SLDB
|
-3.47 | $ 6.57 | 2.5 % | $ 575 M | USA |
 |
Aurora Cannabis
ACB
|
66.7 | $ 3.38 | -0.88 % | $ 185 M | Canada |
 |
Jupiter Wellness
JUPW
|
5.65 | - | - | $ 33.6 M | USA |
 |
Lannett Company
LCI
|
-3.47 | - | 1.15 % | $ 7.11 M | USA |
 |
OrganiGram Holdings
OGI
|
-4.08 | $ 1.08 | 0.93 % | $ 103 M | Canada |
 |
Tilray
TLRY
|
-46 | $ 5.17 | 2.78 % | $ 3.19 B | Canada |
 |
Evolus
EOLS
|
-9.74 | $ 6.7 | 0.3 % | $ 432 M | USA |
 |
Sundial Growers
SNDL
|
-1.27 | $ 1.46 | 0.69 % | $ 3.37 M | Canada |
 |
Veru
VERU
|
-3.28 | $ 3.1 | 3.33 % | $ 45.4 M | USA |
 |
Neoleukin Therapeutics
NLTX
|
0.799 | - | - | $ 193 M | Canada |
 |
cbdMD
YCBD
|
-2.5 | $ 0.72 | -0.69 % | $ 2.9 M | USA |
 |
Assertio Holdings
ASRT
|
28.1 | $ 23.46 | 0.13 % | $ 150 M | USA |
 |
ProPhase Labs
PRPH
|
-4.26 | - | - | $ 5.07 M | USA |
 |
Radius Health
RDUS
|
-13.5 | - | - | $ 1.42 B | USA |
 |
Bausch Health Companies
BHC
|
8.84 | $ 5.17 | 1.17 % | $ 1.92 B | Canada |
 |
PetIQ
PETQ
|
9.82 | - | 1.64 % | $ 400 M | USA |
 |
Relmada Therapeutics
RLMD
|
-4.24 | $ 6.27 | 9.62 % | $ 248 M | USA |
 |
Recro Pharma
REPH
|
47.3 | - | -4.76 % | $ 65.3 M | USA |
 |
OptiNose
OPTN
|
-5.28 | - | - | $ 1.08 B | USA |
 |
SCYNEXIS
SCYX
|
-1.64 | $ 4.36 | -2.02 % | $ 218 M | USA |
 |
PLx Pharma
PLXP
|
-1.84 | - | -27.8 % | $ 2.56 M | USA |
 |
Viatris
VTRS
|
157 | $ 16.2 | 1.69 % | $ 18.9 B | USA |
 |
Zomedica Corp.
ZOM
|
-0.0319 | - | -0.21 % | $ 98 M | USA |
 |
Zynerba Pharmaceuticals
ZYNE
|
0.644 | - | - | $ 55.5 M | USA |
 |
Rockwell Medical
RMTI
|
-17.3 | $ 0.69 | 3.81 % | $ 24.8 M | USA |
 |
Tricida
TCDA
|
-3.64 | - | - | $ 3.25 M | USA |
 |
China Pharma Holdings
CPHI
|
-6.14 | $ 0.72 | 0.75 % | $ 3.09 M |  China |
 |
TherapeuticsMD
TXMD
|
-6.57 | $ 1.88 | - | $ 21.7 M | USA |